Registration Dossier

Administrative data

Endpoint:
developmental toxicity
Type of information:
experimental study planned
Study period:
Results should be available 36 month after final decision
Rationale for reliability incl. deficiencies:
other: see 'Remark'
Remarks:
In compliance with Annex IX, section 8.7.2. a developmental toxicity testing is necessary thus a testing proposal is submitted within the dossier. It is planned a study according to OECD 414 (Prenatal Developmental Toxicity Study) with the test substance Acetoguanamine.

Data source

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 414 (Prenatal Developmental Toxicity Study)

Test material

Constituent 1
Reference substance name:
2,4-Diamino-6-methyl-1,3,5-triazine
IUPAC Name:
2,4-Diamino-6-methyl-1,3,5-triazine
Constituent 2
Chemical structure
Reference substance name:
6-methyl-1,3,5-triazine-2,4-diyldiamine
EC Number:
208-796-3
EC Name:
6-methyl-1,3,5-triazine-2,4-diyldiamine
Cas Number:
542-02-9
Molecular formula:
C4H7N5
IUPAC Name:
6-methyl-1,3,5-triazine-2,4-diyldiamine

Results and discussion

Results (fetuses)

Fetal abnormalities

Abnormalities:
not specified

Overall developmental toxicity

Developmental effects observed:
not specified

Applicant's summary and conclusion